Citation Impact
Citing Papers
Wnt/β-catenin signalling: function, biological mechanisms, and therapeutic opportunities
2022 Standout
ADNP promotes neural differentiation by modulating Wnt/β-catenin signaling
2020
Fugu and human sequence comparison identifies novel human genes and conserved non-coding sequences
2002 StandoutNobel
Timing of therapies for Down syndrome: the sooner, the better
2015
The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics
2011 Standout
Signaling pathway of MAPK/ERK in cell proliferation, differentiation, migration, senescence and apoptosis
2015 Standout
Intranasal NAP administration reduces accumulation of amyloid peptide and tau hyperphosphorylation in a transgenic mouse model of Alzheimer's disease at early pathological stage
2007
Tau-mediated neurodegeneration in Alzheimer's disease and related disorders
2007 Standout
Signaling pathways in schizophrenia: emerging targets and therapeutic strategies
2010
Oxidative stress and the amyloid beta peptide in Alzheimer’s disease
2017 Standout
Searching for IRES
2006
Disruption of the mouse protein Ser/Thr phosphatase 2Cβ gene leads to early pre-implantation lethality
2007 StandoutNobel
Cytokines and chemokines: At the crossroads of cell signalling and inflammatory disease
2014 Standout
The Physiology, Signaling, and Pharmacology of Dopamine Receptors
2011 Standout
Therapeutics of Alzheimer's disease: Past, present and future
2013
Alzheimer’s disease drug-development pipeline: few candidates, frequent failures
2014 Standout
Poly(ADP-ribose): novel functions for an old molecule
2006 Standout
Neuroprotective and neurotoxic properties of glial cells in the pathogenesis of Alzheimer's disease
2008
Anti-Aβ Drug Screening Platform Using Human iPS Cell-Derived Neurons for the Treatment of Alzheimer's Disease
2011 StandoutNobel
Microtubule-stabilizing agent prevents protein accumulation-induced loss of synaptic markers
2007
Alzheimer's Disease
2010 Standout
Alzheimer's disease: clinical trials and drug development
2010
PolyADP-Ribosylation Is Involved in Neurotrophic Activity
2005
Beyond immunotherapy: new approaches for disease modifying treatments for early Alzheimer’s disease
2016
Down syndrome
2020 Standout
Selective Inhibition of Hypoxia-Inducible Factor (HIF) Prolyl-Hydroxylase 1 Mediates Neuroprotection against Normoxic Oxidative Death via HIF- and CREB-Independent Pathways
2009 StandoutNobel
Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders
2011 Standout
Davunetide (NAP) Protects the Retina Against Early Diabetic Injury by Reducing Apoptotic Death
2014
A Neuronal Microtubule-Interacting Agent, NAPVSIPQ, Reduces Tau Pathology and Enhances Cognitive Function in a Mouse Model of Alzheimer’s Disease
2008
Alzheimer's disease
2017 Standout
Alzheimer's Disease and the Amyloid Cascade Hypothesis: A Critical Review
2012
Functional tests of enhancer conservation between distantly related species
2003 StandoutNobel
Conserved regulation of the lymphocyte-specific expression oflckin the Fugu and mammals
2002 StandoutNobel
A Novel Iron-Chelating Derivative of the Neuroprotective Peptide NAPVSIPQ Shows Superior Antioxidant and Antineurodegenerative Capabilities
2007
Therapeutic Potential of Quercetin: New Insights and Perspectives for Human Health
2020 Standout
Seed Germination and Vigor
2012 Standout
Works of Inna Divinski being referenced
NAP and D-SAL: neuroprotection against the β amyloid peptide (1–42)
2008
Uniquely Conserved Non-translated Regions are Involved in Generation of the Two Major Transcripts of Protein Phosphatase 2Cβ
2001
A Femtomolar Acting Octapeptide Interacts with Tubulin and Protects Astrocytes against Zinc Intoxication
2004
Peptide neuroprotection through specific interaction with brain tubulin
2006
The femtomolar-acting NAP interacts with microtubules: Novel aspects of astrocyte protection
2005